Eleusis SPAC

Use of Proceeds SPKB trust account together with existing cash and cash equivalents will be used to support the following: ■ ■ ■ ■ ■ eleusis Clinical development of ELE-Psilo in MDD into Ph2/3 trials Launch and expansion of Andala-managed clinics Drug discovery platform expansion Clinical development of ELE-Psilo in additional areas of high unmet need with proof-of-concept data Working capital and other general corporate purposes 35

View entire presentation